Scarica l'app Stockscreener
1.90
4.52%
-0.09
Dopo l'orario di chiusura:
1.90
Exicure Inc Borsa (XCUR) Ultime notizie
Exicure stock holds its line. Company context stays front and center. - AD HOC NEWS
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0 - TradingView
Enterprise value to EBITDA forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure stock leans on its cash position. Nasdaq listing keeps it visible. - AD HOC NEWS
(XCUR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Exicure refreshes board with new independent directors - TipRanks
New directors join Exicure (NASDAQ: XCUR) board as compensation committee forms - Stock Titan
Exicure announces board changes, adds two new directors By Investing.com - Investing.com Nigeria
Exicure announces board changes, adds two new directors - Investing.com
Press Release: Exicure Announces Board and Committee Changes - Moomoo
Exicure Announces Board and Committee Changes - The Manila Times
Exicure expands board to 6, names 2 new directors - Stock Titan
Price to book forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Enterprise value to revenue forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Price to earnings forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Price to sales forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Enterprise value to EBIT forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure, Inc. Actuals & Estimates (NASDAQ:XCUR) - TradingView
Exicure, Inc. Actuals & Estimates (SWB:2H0) - TradingView
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Q2 2022 Earnings: EPS Misses Estimates by 35.6% as Stock Gains 18.6%EPS Growth Report - dars.gov.et
Exicure StockThursday technicals and trading picture - AD HOC NEWS
Total equity of Exicure, Inc. – DUS:2H0 - TradingView
Exicure, Inc. Balance Sheet – DUS:2H0 - TradingView
Cash from operating activities of Exicure, Inc. – DUS:2H0 - TradingView
Exicure Inc (XCUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value of Exicure, Inc. – DUS:2H0 - TradingView
Exicure Inc (XCUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc. (XCUR) Plunges 22% as Selling Pressure Mounts – Key Support in FocusALMA Signal - newsline.com
XCUR Q2 2022 Earnings: EPS Misses Estimates as Exicure Reports No Revenue and Continues R&D FocusOne-Time Loss Impact - dars.gov.et
XCUR Q2 2022 Earnings: Wider-than-Expected Loss with No Reported RevenueRevenue Warning Signal - newsline.com
Exicure Inc. Q2 2022 Earnings: Significant EPS Miss Amidst No RevenueGAAP Earnings Report - newsline.com
Exicure receives Nasdaq notice for falling below $2.5M equity requirement, plans to regain compliance. - Pluang
Exicure receives Nasdaq notice for equity deficiency - Investing.com
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement - The Manila Times
Exicure receives Nasdaq notice for equity deficiency By Investing.com - Investing.com Canada
XCUR Q2 2022 Earnings: Wider-Than-Expected Loss on No RevenueAnalyst Drop Coverage - newsline.com
Exicure faces Nasdaq listing deadline as equity sits at $2.1M vs $2.5M - Stock Titan
Exicure Inc stock (US30205M1027): biotech penny stock seeks direction after strategic shifts - AD HOC NEWS
XCUR Technical Analysis | Trend, Signals & Chart Patterns | EXICURE INC (NASDAQ:XCUR) - ChartMill
Exicure Inc. (XCUR) Q2 2022 Earnings: Wider-Than-Expected Loss Amid Operational ChallengesQuarterly Earnings - dars.gov.et
Exicure Regains Nasdaq Compliance After Late Quarterly Filing - The Globe and Mail
Exicure Announces Receipt Of Nasdaq Delinquency Notice And Filing Of Form 10-Q - TradingView
Exicure receives Nasdaq notice for delayed quarterly filing By Investing.com - Investing.com South Africa
Exicure receives Nasdaq notice for delayed quarterly filing - Investing.com
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q - The Manila Times
Exicure faces Nasdaq noncompliance over late 10-Q, then files report - Stock Titan
Exicure receives Nasdaq notice for late 10-Q, files report and says compliance restored - TradingView
Exicure (XCUR) addresses Nasdaq delinquency after delayed Q1 2026 10-Q filing - Stock Titan
Exicure, Inc. Q1 2026 Financials: Strategic Alternatives, Going Concern Doubts, and Zero Revenue Reported - Minichart
XCUR Q2 2022 Earnings: EPS Misses Estimates Amid Operational ChallengesProfit Margin Analysis - The Legal Advocate
Exicure Q2 2022 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues DevelopmentEarnings Outlook Update - The Legal Advocate
Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Exicure (NASDAQ: XCUR) posts Q1 2026 loss and flags going concern, Nasdaq risks - Stock Titan
XCUR Q2 2022 Earnings: EPS Miss Widens as Pre-Revenue Biotech Shares Edge HigherEarnings Outlook Update - dars.gov.et
Exicure Deadline Alert - TMX Newsfile
XCUR Q2 2022 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No RevenueFinancial Health Score - newsline.com
Exicure Inc. (XCUR) Q2 2022 Earnings: Wider-than-Expected Loss, No Revenue, Shares Edge Higher - The Legal Advocate
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):